From Diagnosis to Treatment: The Evolution of SSc-ILD
| Overview / Abstract: |
Explore this 45-minute multi-media eNewsletter that will advance your understanding of systemic sclerosis interstitial lung disease (SSc-ILD) with Dr. Ganesh Raghu, Director of the University of Washington Interstitial Lung Disease/Sarcoid/Pulmonary Fibrosis Program. While there have been significant advances in our understanding of SSc-ILD, there are important unmet needs that still must be addressed. These include improvements in the differential diagnosis, advances in therapy, appropriate application of pharmacotherapy, and communicating with patients to improve quality of life, which will be addressed in this activity. Perspectives from patient ambassadors are also included, highlighting their journey and the complexities of diagnosis, treatment, and quality of life. |
|
Expiration |
Aug 27, 2020 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Radiology / RAD Tech CE, Respiratory Therapy CE |
|
Format |
Online |
|
Credits / Hours |
1 |
|
Accreditation |
ACCME |
|
Presenters / Authors / Faculty |
Ganesh Raghu, MD, FCCP, FACP This activity also featured two patients living with SSc-ILD: Patient A and Patient B |
|
Activity Specialities / Related Topics |
Dermatology, Family Medicine, Internal Medicine, Pathology, Primary Care, Pulmonary Medicine / COPD, Radiology / Imagery / Nuclear Medicine, Rheumatology / Arthritis |
|
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. |
|
Keywords / Search Terms |
ACHL ILD, SSc-ILD, interstitial lung disease, systemic sclerosis, Ganesh Raghu, CME, CE, continuing education, continuing medical education, webinar, dermatology, rheumatology, respiratory therapy, pulmonology, nintedanib, pirfenidone, cyclophosphamide, mycophenolate mofetil, LOTUSS, SENSCIS, HRCT Free CE CME |
|